Total Cancer Care Protocol: A Lifetime Partnership

This study, called the Total Cancer Care Protocol, is collecting biological samples (like blood and tissue) and health information from people who have cancer or are at risk of developing it. This is not a treatment study; instead, it aims to build a large collection of data and samples to help researchers better understand cancer and develop new ways to prevent, diagnose, and treat it. The study is open to adults aged 18 and older, including pregnant women, who have cancer or are suspected of having it. The goal is to gather a lot of patient information, medical treatment details, and biological samples over many years to support future cancer research. The current status of this study is unclear.

Study design
This is an observational study planning to enroll 47,500 participants. It is not testing a specific drug or treatment.
What's involved
You would provide permission to study your survey answers, medical records, and to collect blood, tissue, and other biological samples. Data collection will continue for your lifetime.
Compensation
Not stated in the trial record.
Follow-up
Your clinical and related data will be collected from the time you join the study and will continue for life.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT03977402

Total Cancer Care Protocol: A Lifetime Partnership With Patients Who Have or May be at Risk of Having Cancer

Recruiting
Not specifiedAges 18+Observational
New Mexico Cancer Research Alliance
~47,500 participants
Updated 2025-05-22 on ClinicalTrials.gov
What's tested:Biological specimen collection

At a glance

Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Amount of clinical patient demographic data collected for a repository linked to clinical data for long-term research use.
Measured over up to 20 years
+2 more outcomes measured
Cancer
Cancer Risk
1 sites across 1 states
New Mexico1
  • Leslie Andritsos, MD · PRINCIPAL_INVESTIGATOR · University of New Mexico Cancer Center

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

18 years of age and older.
Has a diagnosis of cancer or is suspected of having cancer.
Able to understand and sign the Informed Consent form directly.
Pregnant women are permitted to be enrolled.

Exclusion

Prisoners
  • Amount of clinical patient demographic data collected for a repository linked to clinical data for long-term research use.up to 20 years

    Establish a longitudinal clinical data repository that will contain information about patient demographics collected via surveys and questionnaires.

  • Amount of clinical patient medical treatment and outcome data collected via medical histories for long-term research useup to 20 years

    Establish a longitudinal clinical data repository that will contain information about medical treatments and patient outcomes collected via medical chart review and patient medical histories.

  • Number of biospecimens collected for a tissue repository linked to clinical data for long-term research useup to 20 years

    Establish a longitudinal tissue repository that will contain tissues (blood, tumor tissue) and other biological samples and associated clinical data collected from consenting patients.